MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 40 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,690 | -56.5% | 268,506 | +10.4% | 0.00% | – |
| Q2 2023 | $364,896 | +52.1% | 243,264 | +74.4% | 0.00% | – |
| Q1 2023 | $239,926 | +191.5% | 139,492 | +94.9% | 0.00% | – |
| Q4 2022 | $82,301 | -57.4% | 71,566 | -3.4% | 0.00% | – |
| Q3 2022 | $193,000 | +319.6% | 74,085 | +249.1% | 0.00% | – |
| Q2 2022 | $46,000 | -92.1% | 21,219 | -83.0% | 0.00% | – |
| Q1 2022 | $583,000 | -78.8% | 125,145 | -72.5% | 0.00% | – |
| Q4 2021 | $2,756,000 | +913.2% | 455,068 | +1106.8% | 0.00% | – |
| Q3 2021 | $272,000 | +216.3% | 37,709 | +175.2% | 0.00% | – |
| Q2 2021 | $86,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 309,178 | $671,000 | 0.14% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
| Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
| Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
| M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
| Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
| Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |